Contact this trialFirst, we need to learn more about you.
Hormone Therapy
TransCon PTH for Hypoparathyroidism
Recruiting0 awardsPhase 2
Chicago, Illinois
This trial is testing a new medication, TransCon PTH, to see if it is effective and safe for people with a certain medical condition. The trial will last for four weeks, during which participants will be given either TransCon PTH or a placebo. After the four weeks, all participants will receive TransCon PTH.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.